Ifosfamide, Carboplatin and Etoposide in Recurrent Malignant Glioma

Publisher： Karger

E-ISSN： 1423-0232|80|5-6|330-332

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.5-6, 2011-07, pp. : 330-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ICE (Ifosfamide, Carboplatin, Etoposide) Chemotherapy and Systemic Hyperthermia

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-06 ,pp. : 10-11

Karger

Access to resources Recommend Favorite

Phase II study of salvage therapy with high-dose tamoxifen and oral etoposide for recurrent malignant glioma

By Chang Susan M   Lamborn Kathleen R   Malec Mary   Rabbitt Jane   Page Margaretta   Prados Michael D  

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 53-60

Future Medicine

Access to resources Recommend Favorite

Risk-Adapted Chemotherapy of Germ Cell Tumors with Carboplatin, Etoposide and Bleomycin for Low-Risk and Cisplatin, Etoposide and Ifosfamide for High-Risk Patients

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 110-117

Karger

Access to resources Recommend Favorite

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-08 ,pp. : 413-419

Karger

Access to resources Recommend Favorite

Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma

By  

Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. : 369-372

Karger

Access to resources Recommend Favorite